Some immunologic considerations in focal scleroderma and progressive systemic sclerosis in children.
D000293:Adolescent; D000888:Antibodies, Anti-Idiotypic / Q000032:analysis; D000974:Antibodies, Antinuclear / Q000032:analysis; D001171:Arthritis, Juvenile / Q000276:immunology; D002648:Child; D002675:Child, Preschool; D004247:DNA / Q000378:metabolism; D003609:Dactinomycin; D003882:Dermatomyositis / Q000276:immunology; D005260:Female; D005455:Fluorescent Antibody Technique; D006801:Humans; D005779:Immunodiffusion; D007070:Immunoglobulin A / Q000032:analysis; D007074:Immunoglobulin G / Q000032:analysis; D007075:Immunoglobulin M / Q000032:analysis; D007136:Immunoglobulins / Q000032:analysis*; D007223:Infant; D008180:Lupus Erythematosus, Systemic / Q000276:immunology; D008297:Male; D011863:Radioimmunoassay; D012594:Scleroderma, Localized / Q000276:immunology*; D012595:Scleroderma, Systemic / Q000276:immunology*; D014316:Tritium
D000888:Antibodies, Anti-Idiotypic; D000974:Antibodies, Antinuclear; D007070:Immunoglobulin A; D007074:Immunoglobulin G; D007075:Immunoglobulin M; D007136:Immunoglobulins; D014316:Tritium; D003609:Dactinomycin; D004247:DNA